• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,311.43 281.08
(0.56%)
Dow Jones
7,466.66 12.69
(0.17%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,466.07 33.73
(0.32%)
Forex
USD-INR
96.70 0.18
(0.19%)
EUR-INR
112.25 0.09
(0.08%)
GBP-INR
129.69 0.32
(0.24%)
JPY-INR
0.61 0.00
(0.25%)

EQUITY - MARKET SCREENER

Johnson Pharmacare Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532154
INE560F01022
1.0202255
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
30.8
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

virinchi technologies ltd
CESC slips as Q3 PAT slides 32% QoQ to Rs 304 cr
Feb 06,2026
On a year-on-year basis, the company’s net profit increased 7.8%, supported by a 12.47% growth in net sales in Q3 FY26 compared with Q3 FY25.

Profit before tax (PBT) increased 6.35% YoY to Rs 385 crore in Q3 FY26.

Total expenses increased 7.84% to Rs 3,877 crore in Q3 FY26, compared with Rs 3,595 crore recorded in Q3 FY25. The cost of energy purchased stood at Rs 1,475 crore (up 15.78% YoY), employee benefit expenses were at Rs 391 crore (up 24.92% YoY), and finance costs stood at Rs 343 crore (up 1.18% YoY) during the period under review.

CESC is engaged in the generation and distribution of electricity.